Harm Reduction As Best Practice in Addiction Treatment
The opioid use epidemic has been on the forefront of societal concerns in the U.S. There has been a push by the U.S. Drug Enforcement Administration and other governmental agencies to expand access to education about opioid use disorder (OUD) and other addictions. At the level of Baylor College of Medicine, we have surveyed our emergency medicine colleagues, nursing and technician staff, and have noted a lack of comfort in recognizing and managing OUD. Based on these gaps, this conference will target the educational gaps of diagnosing OUD and provide referral and treatment options within Baylor College of Medicine, Harris Health System, and the Texas Medical Center.
Target Audience
Physicians, fellows, residents, nurses, and other health professionals.
Learning Objectives
At the conclusion of the session, the participants should be able to:
Identify and summarize the evolution of the Opioid Epidemic, its impact on our patients, and current needs of our patient population in terms of treatments.
List and discuss the principles for diagnosing opioid use disorder.
Discuss options for referral and treatment on outpatient basis in the Baylor, Harris Health system and the medical center.
Describe the pharmacological and nonpharmacological treatment options for opioid use disorder, including harm reduction measures.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been designated by Baylor College of Medicine for 0.50 credit of education in medical ethics and/or professional responsibility.
This activity has been designated by Baylor College of Medicine for 0.50 credit of education in pain management and the prescription of opioids.
Available Credit
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Ethics
- 0.50 Pain Management
- 0.50 Participation